Urolithin A vs Resveratrol vs Spermidine

Urolithin A and resveratrol both show up on "longevity" shelves, and both trace part of their story back to plants. But they engage cellular aging through different doors: one supports the physical renewal of mitochondria, the other is best known as a signaling molecule that has been studied as a sirtuin activator. Here is how they actually differ, what the human evidence looks like for each, and how to choose.

The core distinction in one line

Urolithin A is a gut postbiotic that supports mitophagy, the process cells use to recycle worn-out mitochondria so healthier ones can take over. Resveratrol is a plant polyphenol, found in grape skins, red wine and Japanese knotweed, that has been studied primarily as a signaling compound, most famously for its proposed ability to activate SIRT1, a sirtuin enzyme involved in cellular stress responses and metabolism. In short, urolithin A supports the renewal of cellular power plants, while resveratrol is studied mainly as a molecular switch that nudges stress-response pathways.

How resveratrol works, and the honest caveats

Resveratrol became famous through the idea that it could activate sirtuins and mimic some effects associated with calorie restriction. The mechanism, however, is more debated than the headlines suggest. Some laboratory studies show resveratrol can activate SIRT1, while others argue the effect depends heavily on the experimental setup, and researchers continue to discuss whether the activation seen in test tubes translates cleanly to the human body. Beyond sirtuins, resveratrol interacts with several other cellular pathways and behaves as an antioxidant in lab settings.

The bigger practical hurdle is bioavailability. Resveratrol is absorbed but then very rapidly metabolized, so blood levels of the intact molecule stay low and short-lived, which complicates the leap from promising cell data to reliable human outcomes. A systematic review and meta-analysis of randomized trials examining resveratrol's effect on human SIRT1 illustrates how researchers are still working to pin down what supplementation reliably does in people. If your handle exists, our what is resveratrol primer covers the basics in more depth. Resveratrol touches metabolic and cardiovascular topics, so treat it as general support, not a treatment, and speak with your doctor before using it for any health concern.

How urolithin A works

Urolithin A is not consumed directly. Your gut microbiome produces it from ellagitannins, the compounds in pomegranates, walnuts, raspberries and other berries. Crucially, only some people carry the microbial species needed to convert those precursors efficiently, so natural urolithin A levels vary widely from person to person. Supplementing the finished molecule sidesteps that variability.

Rather than acting as a signaling switch the way resveratrol is proposed to, urolithin A supports mitophagy directly: it encourages cells to identify and clear aging or damaged mitochondria so the working pool stays healthier over time. For the underlying biology, see our mitophagy explainer and the broader mitochondrial health guide.

The evidence, organized by strength

Urolithin A: recent human randomized trials

We cite the urolithin A human record precisely and label it. The first-in-human study by Andreux and colleagues (2019, Nature Metabolism) established that urolithin A was safe and well tolerated up to 1,000 mg per day and produced a mitochondrial gene-expression signature in older adults. A 2022 randomized trial in JAMA Network Open (Liu, D'Amico et al.) found improved muscle endurance, measured as contractions before fatigue, in older adults over roughly four months. Singh and colleagues (2022, Cell Reports Medicine) tested 500 mg and 1,000 mg arms in middle-aged adults over four months and reported benefits to muscle strength and exercise performance. A 2025 Nature Aging randomized trial (about 28 days) reported support for immune-cell mitochondrial health in midlife adults, relevant to inflammaging, and a 2024 trial in the Journal of the International Society of Sports Nutrition examined endurance and recovery markers in resistance-trained men over eight weeks. The fair framing comes from a 2024 systematic review in Ageing Research Reviews: the human evidence is promising but still emerging, drawn from short trials with modest sample sizes.

Urolithin A: preclinical foundation

The mechanism was established by Ryu and colleagues (2016, Nature Medicine), animal and cell research showing urolithin A induced mitophagy, extended lifespan in C. elegans, and improved muscle function in rodents. Later preclinical work (D'Amico et al., 2022, Aging Cell) explored joint and cartilage mitochondrial health in osteoarthritis models. These are animal and cell studies, not human proof, and we mark them clearly as such.

Resveratrol: a large but inconsistent literature

Resveratrol has an enormous body of preclinical research and a substantial number of human trials across metabolic, cardiovascular and cognitive endpoints. The results, however, are inconsistent, and much of the excitement still rests on cell and animal data that has been difficult to reproduce reliably in people, partly because of the bioavailability problem noted above. Its story is a useful reminder that a large volume of studies does not automatically translate into dependable human effects for any single goal. Neither compound is a treatment for disease.

Are they complementary?

Urolithin A and resveratrol engage different mechanisms, so they are not interchangeable and are sometimes viewed as complementary within a broader healthy-aging routine: one supports the physical renewal of mitochondria, the other is studied as a signaling nudge to stress-response pathways. That said, there is no head-to-head human trial comparing them, and no strong human evidence that combining them produces additive benefit. Anyone stacking the two is reasoning from mechanism. Because resveratrol can interact with certain medications and affects metabolic pathways, clear any combination with your doctor first.

How to choose by goal

Choose urolithin A if...

Your priority is muscle strength, muscle endurance, exercise performance, or cellular renewal as you age, and you want the option backed by recent, targeted human randomized trials for those specific outcomes, delivered as a molecule with a well-characterized dose. It is also the more sensible pick if you rarely eat pomegranates, walnuts or berries, or suspect you convert them poorly. See urolithin A benefits and the clinical studies overview for detail.

Choose resveratrol if...

You are specifically curious about sirtuin-related signaling and are comfortable with a literature that is large but inconsistent and complicated by low bioavailability. Because resveratrol intersects with metabolic and cardiovascular topics, keep expectations grounded and treat it as general support rather than a fix for any condition. It is not a treatment; see your doctor for any medical question.

A practical starting point for urolithin A

The clinically studied range is 500 to 1,000 mg per day, with 1,000 mg at the top of that range and the dose used in several strength and endurance trials. Our how to take urolithin A and dosage pages walk through the practicalities, the full urolithin A guide gives the complete picture, and our roundup of the best urolithin A gummies explains what to check on a label.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.